HtrA3 can also inhibit lung cancer cell invasion, and the levels of HtrA3 negatively correlate to the increased risk of postoperative recurrence of non-small-cell lung cancer [113]. This evidence concerns the gene HTRA3 and non-small cell lung carcinoma.